​
​

Bellicum Pharmaceuticals Ownership | Who Owns Bellicum Pharmaceuticals?

OverviewChart

Bellicum Pharmaceuticals Ownership Summary

Bellicum Pharmaceuticals is owned by 1.52% institutional investors, and 98.48% retail investors. Vanguard Extended Market Index Investor is the top mutual fund, with 1.01% of its assets in Bellicum Pharmaceuticals shares.

BLCM Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBellicum Pharmaceuticals1.52%-98.48%
SectorHealthcare Stocks 46.80%8.14%45.06%
IndustryBiotech Stocks 44.70%7.99%47.31%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20234-81.82%467,520-67.15%17.12%2-66.67%--100.00%
Mar 31, 202322-26.67%1,423,145-16.67%415.04%6-53.85%525.00%
Dec 31, 20223036.36%1,707,818-3.81%516.71%13160.00%4-20.00%
Sep 30, 202222-4.35%1,775,383-5.16%515.62%5-16.67%525.00%
Jun 30, 202223-1,872,0117.73%619.10%6-33.33%433.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Extended Market Index Investor95.99K1.01%36.63K
Fidelity® Extended Market Index36.62K0.39%-
Fidelity® NASDAQ Composite Index®22.87K0.24%-
BlackRock Extended Mkt Composite8.79K0.09%-
Vanguard U.S. Eq Idx £ Acc6.95K0.07%-
Northern Trust Extended Eq Market Idx6.00K0.06%-
NT Ext Equity Mkt Idx Fd - L6.00K0.06%-
Fidelity® Series Total Market Index5.84K0.06%-
Fidelity® Total Market Index5.35K0.06%-
NT Ext Equity Mkt Idx Fd - NL3.71K0.04%-

Recent Insider Transactions

DateNameRoleActivityValue
Mar 17, 2020Fair Richard A. President and CEOBuy$20.00K
Sep 10, 2019Fair Richard A. President and CEOBuy$50.00K
Aug 29, 2019Ward Shane Sr. VP and General CounselBuy$9.82K
Aug 21, 2019Fair Richard A. President and CEOBuy$19.78K
Nov 09, 2018Stonehouse Jon P-Buy$45.60K

Insider Transactions Trends

DateBuySell
2023 Q4--
2023 Q2--
2023 Q1--
2022 Q3--
2022 Q2--

BLCM Ownership FAQ

Who Owns Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals shareholders are primarily institutional investors at 1.52%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Bellicum Pharmaceuticals's industry, Biotech Stocks , is 44.70%, which Bellicum Pharmaceuticals falls below.

Does Blackrock own Bellicum Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Bellicum Pharmaceuticals.

Who is the top mutual fund holder of Bellicum Pharmaceuticals shares?

Vanguard Extended Market Index Investor is the top mutual fund holder of Bellicum Pharmaceuticals shares, with 1.01% of its total shares outstanding invested in 95.99K Bellicum Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools